Pain Management

Unapproved Cannabidiol, Curcumin Injectables for Multiple Disorders Recalled

By

Brian Park, PharmD

Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.

Racial Differences Seen in Pain Management for Children With Long Bone Fractures

There are racial differences in pain management and pain outcomes for children seen in the emergency department for long-bone fractures.

Antirheumatic Therapy Decreases Opioid Use in Patients With Early Inflammatory Arthritides

By

Morgan E. Meissner

Researchers assessed the effect of the opioid epidemic in Finnish patients with early inflammatory arthritides.

Q&A: Applications of a Novel Joint Preservation Technology in Glenohumeral Osteoarthritis

By

Meghna Rao

Rheumatology Advisor Contributing Writer

In this interview, Gregory P Nicholson, MD, discusses the applications of a novel joint preservation technology in glenohumeral osteoarthritis.

FDA Approves NDA for Diclofenac Sodium Topical Gel 1% for Arthritis Pain

By

Brian Park, PharmD

Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults ≥18 years old.

FDA Approves OTC Combination of Ibuprofen and Acetaminophen for Minor Arthritis Pain

The FDA Advil Dual Action with Acetaminophen for the temporary relief of minor aches and pains due to arthritis and more.

Navigating Patient Pain Under Stricter Opioid Prescribing Laws

Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.

FDA Approves OTC Switch of Diclofenac Gel, Olopatadine Eye Drops

Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.

FDA Clears OTC Electromagnetic Pulse Therapy for Musculoskeletal Pain Relief

The over-the-counter (OTC), drug-free medical device, ActiPatch®, has obtained a new 510(k) clearance from the Food and Drug Administration (FDA) for the adjunctive treatment of musculoskeletal pain.

Effect of Tightening Opioid Regulations in Patients With Chronic Pain

Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.

CDC Urges Caution When Taking Patients Off Opioid Painkillers

Doctors should be more cautious when taking chronic pain patients off opioid painkillers.

Novel Opioid Receptor Agonist Effective for Chronic Low Back Pain

NKTR-181 was found to be a safe, effective, and well tolerated treatment over the long term in patients with moderate to severe chronic low back pain.

Opioid Addiction Treatment Usage Higher in US States With Expanded Medicaid

The use of the opioid addiction medication buprenorphine is much higher in states that expanded Medicaid under the Affordable Care Act than in those that did not expand the program.

Opioid Epidemic: Is Overdose More Likely if a Family Member Has a Prescription?

Investigators examined whether opioid overdose is more likely if a family member has a prescription. We review their findings.

Chronic Joint Pain May Persist for Years After Chikungunya Infection

This is the first study to describe persistent joint pain and stiffness many months after infection with the chikungunya virus.